Aksys
Aksys closes investment by Durus
Published in Pharma Investments, Ventures and Law Weekly, July 30th, 2006
The closing follows the $5 million bridge financing provided to the company by Durus in March 2006.
The company issued new shares of its Series B preferred stock, which are convertible into five million shares of common stock of the company, and warrants to purchase five million shares of the company's common stock in exchange for the cancellation of $5 million of existing subordinated promissory notes of the company currently held by Durus.
In addition, at the closing Durus provided approximately...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma
Dutton Associates announces investment opinion update on A.P. Pharma - Adnexus Therapeutics
Adnexus Therapeutics closes $27 million series B funding - Angiotech
Angiotech Pharmaceuticals completes acquisition of Quill Medical - Auxilium
Auxilium files registration statement for previously issued securities - Avidia
Avidia expands senior management team - Barr
Barr announces offer of $2.2 billion for Pliva - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
